Exscientia is 10 years old this July!
July 2022 "Today we are celebrating ten years of Exscientia! Founded as a spinout from the University of Dundee on 20 July 2012,...
top of page
Ecosystem
Beta Site
Blog: Blog2
GPCR News
Search
GPCR News
Jun 30, 20221 min read
X4 slashes pipeline, lays off staff just three weeks after netting a $55M PIPE
July 2022 "Not even a PIPE financing could save X4 Pharmaceuticals from enacting layoffs and trimming its pipeline. The Boston biotech...
10
GPCR News
Jun 30, 20221 min read
Dr. Ross Bathgate becomes Scientific co-founder of LASEREDD Therapeutics
July 2022 "I’m happy to share that I’m starting a new position as Scientific co-founder LASEREDD Therapeutics" Ross Bathgate Read more at...
30
GPCR News
Jun 30, 20221 min read
Confo Therapeutics receives €1.7 million VLAIO grant for further research on GPCR modulators for ...
July 2022 Confo Therapeutics receives €1.7 million VLAIO grant for further research on GPCR modulators for rare diseases "29/06/2022...
20
GPCR News
Jun 30, 20221 min read
Sosei Heptares recently hosted their annual Scientific Advisory Board (SAB)
"We recently hosted our annual Scientific Advisory Board (SAB) summit at our site within Granta Park. It was great to bring everyone...
00
GPCR News
Jun 30, 20221 min read
Orion and Peptilogics are pursuing AI-driven drug discovery to explore new functional chemical ...
July 2022 "Orion Biotechnology and Peptilogics are pursuing AI-driven drug discovery to explore new functional chemical space and...
60
GPCR News
Jun 30, 20221 min read
Tectonic Therapeutic Strengthens Leadership Team
July 2022 "July 19, 2022 07:00 AM Eastern Daylight Time BOSTON--Tectonic Therapeutic, Inc. a pre-clinical stage biotechnology company...
20
GPCR News
Jun 30, 20221 min read
Addex raises $4.2 million in equity financing
July 2022 "Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 22, 2022 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq:...
10
GPCR News
Jun 30, 20221 min read
Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate ...
July 2022 Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate into clinical trials "HTL0039732...
10
GPCR News
May 31, 20221 min read
Third Rock pushes newest fund over $1B line as it marks 15 years in venture capital
June 2022 "June 15, 2022 06:30 AM EDT - In 2016, Abbie Celniker was promoted to partner at Third Rock Ventures as the firm raised just...
00
GPCR News
May 31, 20221 min read
Orion Shares New Data on its Latest Best-in-Class Drug Candidate
June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the...
70
GPCR News
May 31, 20221 min read
Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
June 2022 "G protein-coupled receptors (GPCRs) represent a major therapeutic target class as they play a key role in many (patho-)...
30
GPCR News
May 31, 20221 min read
Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital ...
June 2022 Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital Adrenal Hyperplasia at ENDO...
10
GPCR News
May 31, 20221 min read
Michel Bouvier appointed Knight of the Ordre national du Québec
June 2022 "Published on juin 22, 2022 On June 22, 2022, Michel Bouvier, Chief Executive Officer of IRIC, Principal Investigator of the...
20
GPCR News
May 31, 20221 min read
Crinetics Presents Clinical And Research Results At ENDO 2022
June 2022 "CRN04894 Selected for Oral Presentation SAN DIEGO, June 8, 2022 — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), announced...
10
GPCR News
May 31, 20221 min read
GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
June 2022 "We’re delighted to welcome Dr Ed Brennan as our new Vice President, Head of Clinical Development. Dr Brennan has extensive...
30
GPCR News
Apr 30, 20221 min read
Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
May 2022 Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR Targets for Drug Discovery...
00
GPCR News
Apr 30, 20221 min read
Targeting the M1 muscarinic receptor in neurodegenerative disease
April 2022 "By Sophie Bradley | Apr 12, 2022 Summary Sophie Bradley, Translational Sciences Associate Director at Sosei Heptares,...
10
GPCR News
Apr 30, 20221 min read
Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
May 2022 "MONTREAL (CANADA) – May 17, 2022 – Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique...
20
GPCR News
Apr 30, 20221 min read
AcroScreen co-founder Margaux Duchamp has been selected as a 30 under 30 Europe Forbes ranking 2022
May 2022 "We are thrilled to announce that our co-founder Margaux Duchamp has been selected as a 30 under 30 Europe Forbes ranking 2022...
40
bottom of page